These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Reported results 2004-002380-24 An open randomised, prospective, multi-centre, parallel-group trial to compare efficacy and safety of TachoSil versus standard surgical treatment in patients undergoing pulmonary lobectomy for lung ma... 2008-03-31 due-trials
Completed, but no date, and reported results Terminated 2004-005028-42 A prospective, multi-centre, phase III-b study of TachoSil in paediatric patients scheduled for resection of the liver with or without segmental liver transplantation bad-data
Reported results 2005-000730-20 An open label, international, multi centre, parallel group, phase III b, randomised trial, investigating lumbar spine Bone Mineral Density (BMD) changes in postmenopausal women with primary osteoporos... 2011-01-14 due-trials
Reported results 2005-002347-82 Intranasal fentanyl for the treatment of breakthrough pain in cancer patients: A randomised, double-blind, placebo-controlled, cross-over confirmatory trial testing the doses 50, 100 and 200 µg fentan... 2007-05-13 due-trials
Reported results 2005-002348-24 A double-blind, randomised, placebo-controlled trial confirming the efficacy of intranasal fentanyl titrated to 50, 100 or 200 µg with an open long-term safety follow-up in cancer patients with breakt... 2008-08-29 due-trials
Reported results 2005-003485-42 Treatment response in patients with symptoms due to gastroesophageal reflux disease either with or without esophagitis treated with pantoprazole sodium 40 mg o.d. over 8 weeks 2007-08-14 due-trials
Reported results 2005-003937-42 Effect of roflumilast on exacerbation rate in patients with COPD A 52 weeks, double-blind study with 500 mcg roflumilast once daily versus placebo 2008-09-25 due-trials
Reported results 2005-003938-18 Effect of roflumilast on exacerbation rate in patients with COPD. A 52 weeks, double-blind study with 500 mcg roflumilast once daily versus placebo 2008-08-14 due-trials
Reported results 2005-005080-28 Effect of roflumilast in COPD patients treated with salmeterol. A 24 week, double blind study with 500 mcg roflumilast once daily versus placebo 2008-02-12 due-trials
Reported results 2005-005702-23 Efficacy of 500µg roflumilast once daily versus placebo over 12 weeks in patients with diabetes mellitus type 2. A double blind, parallel group, phase IIb, proof of concept clinical study 2008-01-29 due-trials
Reported results 2006-000028-15 A randomised, open label, parallel-group, multi-centre trial to compare the efficacy and safety of TachoSil versus standard haemostatic treatment in cardiovascular surgery 2007-12-17 due-trials
Reported results 2006-000803-40 A comparative study of inhaled ciclesonide versus placebo in children with asthma (RAINBOW) 2007-11-29 due-trials
Reported results 2006-000927-33 Confirmation of superiority of complete remission concept vs classical healing concept for treatment of patients with erosive GERD 2007-10-11 due-trials
Reported results 2006-002087-26 An open label, comparative, randomised, balanced crossover trial comparing nasal fentanyl and oral transmucosal fentanyl (Actiq) in breakthrough pain in patients with cancer 2008-09-05 due-trials
Completed, but no date, and reported results Terminated 2006-004007-19 A multi-centre, double-blind, placebo-controlled, randomised, parallel group clinical trial to evaluate efficacy and safety of Actovegin® in diabetic type 2 patients with symptomatic diabetic peripher... bad-data
Reported results 2006-004508-37 Effect of roflumilast in COPD patients treated with tiotropium. A 24-week, double-blind study with 500 g roflumilast once daily versus placebo. 2008-07-07 due-trials
Ongoing 2006-005570-42 "Ensayo clínico multicéntrico, longitudinal, prospectivo, fase IV que compara dos técnicas de imagen (ImaTx y DXA) para evaluar el efecto anabólico de la PTH (1-84) en mujeres postmenopáusicas con... not-yet-due
Not reported 2006-006064-32 A 24-week, international, multi centre, randomised, double-blind, double-dummy, parallel group, phase IV clinical trial investigating changes in back pain in postmenopausal women with an osteoporosis ... 2010-05-06 due-trials
Reported results 2006-006065-16 A 24-week, international, multi centre, randomised, open label, parallel group, phase IV clinical trial investigating changes in bone formation markers in postmenopausal women with primary osteoporosi... 2009-01-26 due-trials
Reported results 2007-003736-34 Effect of low dose continuous treatment with Ciclesonide over one year on the time to first exacerbation in children with mild asthma versus intermittent treatment for exacerbations 2009-06-25 due-trials
Reported results 2007-006121-26 An international, randomised, double blinded, multi-centre, active- and placebo-controlled dose response trial to evaluate the efficacy and safety of SABER-Bupivacaine for postoperative pain control i... 2010-06-01 due-trials
Reported results 2007-006122-96 An international, randomised, double blinded, multi-centre, active- and placebo-controlled dose response trial to evaluate the efficacy and safety of SABER-Bupivacaine for postoperative pain control i... 2011-02-04 due-trials
Reported results 2007-007254-62 Non-randomised, open, multi-center trial evaluating feasibility and safety of TachoSil application on a colorectal anastomosis. 2009-07-16 due-trials
Reported results 2009-013056-71 Ensayo abierto, aleatorizado, multicentrico, controlado con grupo paralelo para evaluar la eficacia y seguridad de TachoSilâ frente a la práctica habitual en técnicas de sellado de duramadre para la... 2013-09-06 due-trials
Reported results 2009-015589-74 A controlled, randomized, double-blind, cross-over study of the onset of analgesic effect of two formulations of ibuprofen for the treatment of pain after oral surgery. 2010-03-29 due-trials
Reported results 2010-019685-87 Effect of roflumilast on exacerbation rate in patients with COPD treated with fixed combinations of LABA and ICS. A 52-week, randomised double-blind trial with roflumilast 500 ?g versus placebo Efe... 2014-07-31 due-trials
Reported results 2010-021096-85 A dose titrated clinical trial with a placebo-controlled, double-blind, randomised, cross-over phase to demonstrate the efficacy of 400 μg Intranasal fentanyl (INFS) dose strength, and to evaluate 12 ... 2013-01-02 due-trials
Reported results Terminated 2010-022378-15 VELVET (Veltuzumab various doses exploratory trial), a randomized, double blind, placebo controlled, multicentre, multinational phase II dose range finding trial in subjects with moderate to severe rh... 2012-10-01 due-trials
Not reported Terminated 2011-002101-29 A randomised, double-blind, 4-weeks cross-over trial to investigate the effect of 500 µg roflumilast tablets once-daily versus placebo on pulmonary function, asthma symptoms and inflammatory markers i... 2012-01-26 due-trials
Reported results Terminated 2011-002905-31 Effect of roflumilast 500 μg tablets once daily at acute COPD exacerbations treated with standard therapy of oral steroids and antibiotics. A randomised, double-blind, placebo-controlled, parallel-gro... 2014-04-14 due-trials